| AAV | Adeno-associated virus |
| AAV9 | Adeno-associated virus serotype 9 |
| AKT | Protein kinase B |
| APC | Adenomatous-polyposis-coli |
| BL | Blue light |
| bFGF | Basic fibroblast growth factor |
| CAG | CMV early enhancer/chicken β actin |
| CaMKII | Ca2+/calmodulin-dependent protein kinase II |
| cAMP | Cyclic adenosine monophosphate |
| ChR2 | Channelrhodopsin-2 |
| CREB | cAMP-responsive element-binding protein |
| CSPG | Chondroitin sulphate proteoglycan |
| DAPI | 4′,6-diamidino-2-phenylindole |
| EGF | Epidermal growth factor |
| EPAC2 | Exchange protein directly activated by cAMP |
| ERK | Extracellular-signal-related kinase |
| GFAP | Glial fibrillary acidic protein |
| GSK3β | Glycogen synthase kinase 3β |
| HBSS | Hanks Balanced Salt Solution |
| hChR2 | Humanized channelrhodopsin-2 |
| mTOR | Mammalian target of rapamycin |
| NGS | Normal goat serum |
| NF-κB | Nuclear Factor κB |
| NPC | Neural progenitor cell |
| LIF | Leukaemia inhibitory factor |
| LPA | Lysophosphatidic acid |
| Olig2 | Oligodendrocyte transcription factor 2 |
| PI3K | Phosphoinositide 3-kinase |
| SCI | Spinal cord injury |
| Stat3 | Signal transducer and activator of transcription 3 |
| VGCC | Voltage-gated calcium channel |